{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:22:06Z","timestamp":1782890526730,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme (I.A.) Corp. provided funding for this research project.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12889-018-5247-6","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:00:24Z","timestamp":1522796424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Wan-Hsuan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Kung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Yuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"key":"5247_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2334-9-55","volume":"9","author":"A Gil","year":"2009","unstructured":"Gil A, Gil R, Alvaro A, San Martin M, Gonzalez A. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004). BMC Infect Dis. 2009;9:55.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 2","key":"5247_CR2","first-page":"40","volume":"14","author":"LQ Araujo","year":"2007","unstructured":"Araujo LQ, Macintyre CR, Vujacich C. Epidemiology and Burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America. Herpesviridae. 2007;14(Suppl 2):40\u20134.","journal-title":"Herpesviridae"},{"key":"5247_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1742-1241.2009.02089.x","volume":"63","author":"RW Johnson","year":"2009","unstructured":"Johnson RW, McElhaney J. Postherpetic neuralgia in the elderly. Int J Clin Pract. 2009;63:1386\u201391.","journal-title":"Int J Clin Pract"},{"key":"5247_CR4","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1016\/j.jaad.2007.09.017","volume":"57","author":"RF Betts","year":"2007","unstructured":"Betts RF. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia. J Am Acad Dermatol. 2007;57:S143\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"5247_CR5","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271\u201384.","journal-title":"N Engl J Med"},{"key":"5247_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/cid\/cir970","volume":"54","author":"KE Schmader","year":"2012","unstructured":"Schmader KE, Levin MJ, Gnann JW Jr, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012;54:922\u20138.","journal-title":"Clin Infect Dis"},{"key":"5247_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/jama.2010.1983","volume":"305","author":"HF Tseng","year":"2011","unstructured":"Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305:160\u20136.","journal-title":"JAMA"},{"key":"5247_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/1471-2334-13-586","volume":"13","author":"M Studahl","year":"2013","unstructured":"Studahl M, Petzold M, Cassel T. Disease burden of herpes zoster in Sweden--predominance in the elderly and in women - a register based study. BMC Infect Dis. 2013;13:586.","journal-title":"BMC Infect Dis"},{"key":"5247_CR9","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.vaccine.2009.11.029","volume":"28","author":"YH Lin","year":"2010","unstructured":"Lin YH, Huang LM, Chang IS, et al. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine. 2010;28:1217\u201320.","journal-title":"Vaccine"},{"key":"5247_CR10","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.1016\/j.vaccine.2010.09.074","volume":"28","author":"S Gonzalez Chiappe","year":"2010","unstructured":"Gonzalez Chiappe S, Sarazin M, Turbelin C, et al. Herpes zoster: Burden of disease in France. Vaccine. 2010;28:7933\u20138.","journal-title":"Vaccine"},{"key":"5247_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jmv.23830","volume":"86","author":"WS Choi","year":"2014","unstructured":"Choi WS, Kwon SS, Lee J, et al. Immunity and the burden of herpes zoster. J Med Virol. 2014;86:525\u201330.","journal-title":"J Med Virol"},{"key":"5247_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","volume":"27","author":"AN Stein","year":"2009","unstructured":"Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine. 2009;27:520\u20139.","journal-title":"Vaccine"},{"key":"5247_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2334-11-173","volume":"11","author":"B Ultsch","year":"2011","unstructured":"Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173.","journal-title":"BMC Infect Dis"},{"key":"5247_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2165\/00019053-200725020-00007","volume":"25","author":"RP Insinga","year":"2007","unstructured":"Insinga RP, Itzler RF, Pellissier JM. Acute\/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans. PharmacoEconomics. 2007;25:155\u201369.","journal-title":"PharmacoEconomics"},{"key":"5247_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1471-2334-10-230","volume":"10","author":"LE Gialloreti","year":"2010","unstructured":"Gialloreti LE, Merito M, Pezzotti P, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:230.","journal-title":"BMC Infect Dis"},{"key":"5247_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4065\/84.9.787","volume":"84","author":"BP Yawn","year":"2009","unstructured":"Yawn BP, Itzler RF, Wollan PC, Pellissier JM, Sy LS, Saddier P. Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc. 2009;84:787\u201394.","journal-title":"Mayo Clin Proc"},{"key":"5247_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijid.2013.11.018","volume":"20","author":"H Song","year":"2014","unstructured":"Song H, Lee J, Lee M, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014;20:23\u201330.","journal-title":"Int J Infect Dis"},{"key":"5247_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2165\/11317560-000000000-00000","volume":"27","author":"RR White","year":"2009","unstructured":"White RR, Lenhart G, Singhal PK, et al. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. PharmacoEconomics. 2009;27:781\u201392.","journal-title":"PharmacoEconomics"},{"key":"5247_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/ijd.12484","volume":"54","author":"TF Tsai","year":"2015","unstructured":"Tsai TF, Yao CA, Yu HS, et al. Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study. Int J Dermatol. 2015;54:529\u201336.","journal-title":"Int J Dermatol"},{"key":"5247_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/OLQ.0b013e318244ac4c","volume":"39","author":"TM Keating","year":"2012","unstructured":"Keating TM, Kurth AE, Wald A, Kahle EM, Barash EA, Buskin SE. Clinical burden of herpes simplex virus disease in people with human immunodeficiency virus. Sex Transm Dis. 2012;39:372\u20136.","journal-title":"Sex Transm Dis"},{"key":"5247_CR21","doi-asserted-by":"publisher","first-page":"ofu049","DOI":"10.1093\/ofid\/ofu049","volume":"1","author":"JA Suaya","year":"2014","unstructured":"Suaya JA, Chen SY, Li Q, Burstin SJ, Levin MJ. Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States. Open Forum Infect Dis. 2014;1:ofu049.","journal-title":"Open Forum Infect Dis"},{"key":"5247_CR22","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1017\/S0950268811002640","volume":"140","author":"J Bilcke","year":"2012","unstructured":"Bilcke J, Ogunjimi B, Marais C, et al. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect. 2012;140:2096\u2013109.","journal-title":"Epidemiol Infect"},{"key":"5247_CR23","first-page":"99","volume":"15","author":"FY Hsiao","year":"2007","unstructured":"Hsiao FY, Yang CL, Huang YT, Huang WF. Using Taiwan's National Health Insurance Research Databases for pharmacoepidemiology research. J Food Drug Anal. 2007;15:99\u2013108.","journal-title":"J Food Drug Anal"},{"key":"5247_CR24","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/sim.2053","volume":"24","author":"PC Austin","year":"2005","unstructured":"Austin PC, Mamdani MM, Stukel TA, Anderson GM, Tu JV. The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med. 2005;24:1563\u201378.","journal-title":"Stat Med"},{"key":"5247_CR25","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130\u20139.","journal-title":"Med Care"},{"key":"5247_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0895-4356(96)00271-5","volume":"49","author":"W D'Hoore","year":"1996","unstructured":"D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49:1429\u201333.","journal-title":"J Clin Epidemiol"},{"key":"5247_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46:399\u2013424.","journal-title":"Multivar Behav Res"},{"key":"5247_CR28","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1002\/sim.727","volume":"20","author":"P Armitage","year":"2001","unstructured":"Armitage P. Theory and practice in medical statistics. Stat Med. 2001;20:2537\u201348.","journal-title":"Stat Med"},{"key":"5247_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2307\/1910133","volume":"28","author":"G Chow","year":"1960","unstructured":"Chow G. Tests of equality between sets of coefficients in two linear regressions. Econometrica. 1960;28:591\u2013605.","journal-title":"Econometrica"},{"key":"5247_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s15010-013-0550-8","volume":"42","author":"SY Chen","year":"2014","unstructured":"Chen SY, Suaya JA, Li Q, et al. Incidence of herpes zoster in patients with altered immune function. Infection. 2014;42:325\u201334.","journal-title":"Infection"},{"key":"5247_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2334-12-110","volume":"12","author":"JG Pierik","year":"2012","unstructured":"Pierik JG, Gumbs PD, Fortanier SA, Van Steenwijk PC, Postma MJ. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis. 2012;12:110.","journal-title":"BMC Infect Dis"},{"key":"5247_CR32","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","volume":"14","author":"B Ultsch","year":"2013","unstructured":"Ultsch B, Koster I, Reinhold T, et al. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ. 2013;14:1015\u201326.","journal-title":"Eur J Health Econ"},{"key":"5247_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2334-13-170","volume":"13","author":"S Pinchinat","year":"2013","unstructured":"Pinchinat S, Cebrian-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013;13:170.","journal-title":"BMC Infect Dis"},{"key":"5247_CR34","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/1346-8138.13639","volume":"44","author":"K Sato","year":"2017","unstructured":"Sato K, Adachi K, Nakamura H, et al. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: results from an observational, prospective, physician practice-based cohort study. J Dermatol. 2017;44:414\u201322.","journal-title":"J Dermatol"},{"key":"5247_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268803001523","volume":"132","author":"DM Fleming","year":"2004","unstructured":"Fleming DM, Cross KW, Cobb WA, Chapman RS. Gender difference in the incidence of shingles. Epidemiol Infect. 2004;132:1\u20135.","journal-title":"Epidemiol Infect"},{"key":"5247_CR36","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20:748\u201353.","journal-title":"J Gen Intern Med"},{"key":"5247_CR37","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/jmv.21599","volume":"81","author":"N Toyama","year":"2009","unstructured":"Toyama N, Shiraki K. Epidemiology of herpes zoster and its relationship to varicella in Japan: a 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol. 2009;81:2053\u20138.","journal-title":"J Med Virol"},{"key":"5247_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077709","volume":"8","author":"PY Wu","year":"2013","unstructured":"Wu PY, Wu HD, Chou TC, Sung FC. Varicella vaccination alters the chronological trends of herpes zoster and varicella. PLoS One. 2013;8:e77709.","journal-title":"PLoS One"},{"issue":"5","key":"5247_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","volume":"19","author":"W Opstelten","year":"2002","unstructured":"Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002;19(5):471.","journal-title":"Fam Pract"},{"key":"5247_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijid.2015.03.022","volume":"34","author":"K Kawai","year":"2015","unstructured":"Kawai K, Rampakakis E, Tsai TF, et al. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from north and Latin America and Asia. Int J Infect Dis. 2015;34:126\u201331.","journal-title":"Int J Infect Dis"},{"key":"5247_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","volume":"157","author":"HJ Forbes","year":"2016","unstructured":"Forbes HJ, Thomas SL, Smeeth L, et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157:30\u201354.","journal-title":"Pain"},{"key":"5247_CR42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s12879-014-0637-6","volume":"14","author":"H Bricout","year":"2014","unstructured":"Bricout H, Perinetti E, Marchettini P, et al. Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study. BMC Infect Dis. 2014;14:637.","journal-title":"BMC Infect Dis"},{"key":"5247_CR43","first-page":"1091","volume":"72","author":"L Torcel-Pagnon","year":"2017","unstructured":"Torcel-Pagnon L, Bricout H, Bertrand I, et al. Impact of underlying conditions on zoster-related pain and on quality of life following zoster. J Gerontol A Biol Sci Med Sci. 2017;72:1091\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"5247_CR44","doi-asserted-by":"publisher","first-page":"e3304","DOI":"10.1097\/MD.0000000000003304","volume":"95","author":"MJ Hong","year":"2016","unstructured":"Hong MJ, Kim YD, Cheong YK, Park SJ, Choi SW, Hong HJ. Epidemiology of Postherpetic neuralgia in Korea: an electronic population health insurance system based study. Medicine (Baltimore). 2016;95:e3304.","journal-title":"Medicine (Baltimore)"},{"key":"5247_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1212\/WNL.0000000000002808","volume":"87","author":"HJ Forbes","year":"2016","unstructured":"Forbes HJ, Bhaskaran K, Thomas SL, et al. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: a cohort study. Neurology. 2016;87:94\u2013102.","journal-title":"Neurology"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5247-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-018-5247-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5247-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T20:16:32Z","timestamp":1553026592000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-5247-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5247"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-5247-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]},"assertion":[{"value":"18 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of the National Taiwan University Hospital (201,411,050\u00a0W), and access to the National Health Insurance Research Database (NHIRD) was permitted by the National Health Research Institutes (NHRI) in Taiwan. Since the identification numbers of all subjects in the NHIRD were encrypted to protect the privacy of the individuals, this study was exempted from full review by the institutional review board and informed consents were waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FYH, LKC, WHL, and CYW received a research grant sponsored by Merck Sharp & Dohme (I.A.) Corp.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"369"}}